The team indicated that Sharpe will be reevaluated in six months. This timeline provides a clear indication of potential recovery progress into the 2026-27 season, though a six-month check is not a return date. The exact timing for Sharpe’s return to basketball activities or game action was not disclosed.
In the 2025-26 season, Sharpe delivered a career-best offensive performance, averaging a career-high 20.8 points, along with 4.3 rebounds and 2.6 assists over 50 regular-season games. He shot 45.2% from the field and continued to raise his scoring average for the fourth straight season. As the No. 7 overall pick in 2022, Sharpe quickly emerged as a key young contributor for Portland.
The injury comes at a challenging moment for the Blazers, who had just begun positioning Sharpe as a central piece in their lineup. Portland reinforced its commitment to Sharpe with a multi-year contract extension in October 2025, underscoring the organization’s belief in his potential and development. General manager Joe Cronin described Sharpe as “one of the most exciting young players in the NBA” at the time of the deal.
Sharpe’s absence will affect how the Blazers manage minutes and touches in a backcourt that includes a mix of established and rising talents. Portland has built depth at guard, including Jrue Holiday and Scoot Henderson, while also adding former All-Star Ja Morant in a trade during June. Morant’s arrival adds another dynamic to Portland’s backcourt and presents new questions about shot opportunities and offensive distribution among the group.
Sharpe’s size and athleticism—standing 6-foot-5 and serving as a scoring option alongside Portland’s primary ballhandlers—made him a versatile and valuable contributor. His 20.8 points per game from the previous season underscored his expanding role and the importance of his development as the team looked to build on its return to the postseason, after finishing seventh in the Western Conference and advancing to the first round before being swept in five games.
With Sharpe sidelined for the foreseeable future, the Blazers will rely on their depth and strategic load management as they plan for his eventual comeback. The six-month reevaluation will be a critical milestone to determine whether Sharpe can return later in the 2026-27 season or if recovery extends beyond that timeframe.
As the rehabilitation process continues, the team has not provided a definitive timeline for Sharpe’s on-court activities. Fans and analysts will be watching closely for updates on his progression and any signs of movement toward a return to game action.
